ArticleFrontiers in immunology2018

iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis.

Alexandre T J Maria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.